Previous studies have shown beneficial effects of TRF to reduce inflammation in individuals with obesity or metabolic diseases3,22,38, and we have shown that eTRF reduces inflammation in individuals without obesity, in the form of reductions in the plasma concentrations of TNF-α and IL-8. This evidence concerns the gene CXCL8 and obesity due to melanocortin 4 receptor deficiency.